SG Americas Securities LLC bought a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 10,384 shares of the financial services provider's stock, valued at approximately $387,000.
A number of other hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. raised its stake in Trupanion by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock valued at $173,362,000 after buying an additional 45,653 shares in the last quarter. Marshall Wace LLP boosted its holdings in Trupanion by 6.9% in the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider's stock worth $43,459,000 after purchasing an additional 57,804 shares during the period. Balyasny Asset Management L.P. increased its stake in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after purchasing an additional 661,559 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Trupanion by 9.0% during the fourth quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock worth $17,749,000 after purchasing an additional 30,549 shares during the period. Finally, BNP Paribas Financial Markets lifted its position in shares of Trupanion by 170.7% in the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock worth $16,248,000 after buying an additional 212,545 shares during the last quarter.
Trupanion Stock Performance
Shares of Trupanion stock traded down $1.20 during trading on Wednesday, hitting $55.25. 335,573 shares of the stock were exchanged, compared to its average volume of 609,842. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.70 and a current ratio of 1.70. Trupanion, Inc. has a 12 month low of $26.27 and a 12 month high of $57.90. The stock's fifty day moving average is $45.35 and its 200 day moving average is $43.70. The stock has a market cap of $2.36 billion, a PE ratio of -552.44 and a beta of 1.81.
Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.02. Trupanion had a negative net margin of 0.32% and a negative return on equity of 1.33%. The company had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. During the same quarter last year, the business earned ($0.16) earnings per share. Trupanion's revenue was up 11.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.
Insiders Place Their Bets
In related news, CEO Margaret Tooth sold 4,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total transaction of $183,440.00. Following the sale, the chief executive officer now owns 118,784 shares of the company's stock, valued at $5,447,434.24. The trade was a 3.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Fawwad Qureshi sold 2,534 shares of Trupanion stock in a transaction on Thursday, May 29th. The shares were sold at an average price of $48.31, for a total value of $122,417.54. Following the transaction, the chief financial officer now owns 3,545 shares in the company, valued at approximately $171,258.95. This trade represents a 41.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,562 shares of company stock worth $678,230. 5.42% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Separately, Lake Street Capital lowered their price objective on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research report on Friday, May 2nd. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, Trupanion presently has a consensus rating of "Moderate Buy" and an average price target of $51.80.
Check Out Our Latest Stock Report on TRUP
About Trupanion
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
